Effect of Serum Amyloid A on Cellular Affinity of Low Density Lipoprotein

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 6, 1997, Pages 421-426

  Yamada, Toshiyuki ^a   Yamaguchi, Tetsuji ^a   Itoh, Yoshihisa ^a   Miida, Takashi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SERUM AMYLOID A;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST;

ADULT; ANIMALS; APOLIPOPROTEINS; CELL LINE; CELLS, CULTURED; FIBROBLASTS; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MACROPHAGES; MICE; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; SKIN;

ANIMALIA; MURINAE;

EID: 0030811889     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.6.421     Document Type: Article

References (28)

1. Stone MJ. Amyloidosis. A final common pathway for protein deposition in tissues. Blood 1990: 75: 531-545.
2. Husby G, Marhaug G, Downton B, Sletten K, Sipe JD. Serum amyloid A (SAA). Biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int J Exp Clin Invest 1994: 1: 119-137.
3. Dwulet FE, Wallace DK, Benson MD. Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual. Biochemistry 1988: 27: 1677-82.
4. Whitehead AS, de Beer MC, Kits M, Lelias JM, Lane WS, de Beer FC. Identification of novel members of serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992: 267: 3862-7.
5. Baba S, Takahashi T, Kasama T, Fujie M, Shirasawa H. A novel polymorphism of human serum amyloid A protein, SAA1, is characterized by alanines at both residues 52 and 57. Biochim Biophys Acta 1992: 1180: 195-200.
6. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sei 1982: 389: 39-48.
7. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, et al. Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994: 180: 203-210.
8. Mitchell TI, Coon CI, Brinckerhoff CE. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J Clin Invest 1991: 87: 1177-85.
9. Zimlichman S, Danon A, Nathan I, Moses G, Shaikin-Kestenbaum R. Serumamyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Invest 1990: 116: 180-186.
10. Yamada T, Kluve-Beckerman B, Küster WM, Liepnieks JJ, Benson MD. Measurement of serum amyloid A4 (SAA4). Its constitutive presence in serum. Amyloid Int J Exp Clin Invest 1994: 1: 114-118.
11. Yamada T, Kluve-Beckerman B, Liepnieks JJ, Benson MD. Fibril formation from recombinant human serum amyloid A. Biochim Biophys Acta 1994: 1226: 323-329.
12. Benditt EP, Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human sera. Proc Natl Acad Sei USA 1977: 74: 4025-8.
13. Marhaug G, Sletten K, Husby G. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apo-SAA). Clin Exp Immunol 1982: 50: 382-389.
14. de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 1995: 36: 526-534.
15. Yamada T, Miida T, Itoh Y, Kawai T, Benson MD. Characterization of serum amyloid A4 as a plasma lipoprotein. Clin Chim Acta 1996: 251: 105-112.
16. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3: density, size and apolipoprotein composition. J Biol Chem 1986: 261: 9644-51.
17. Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart J-C. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989: 1006: 173-178.
18. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein cellular affinity. Lab Invest 1992: 66: 778-785.
19. Liang J, Sipe JD. Recombinant human serum amyloid A (apo-SAAp) binds cholesterol and modulates cholesterol flux. J Lipid Res 1995: 36: 37-46.
20. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK: de Beer FC. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 1995: 36: 1058-65.
21. Van Lenten BJ, Kama SY, de Beer FC, Stafforini DM, Mclntyre TM, Prescott SM, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. J Clin Invest 1995: 96: 2758-67.
22. Yamada T, Kakihara T, Kamishima T, Fukuda T, Kawai T. Both acute phase and constitutive serum amyloid A are present in the atherosclerotic lesions. Pathol Int 1996: 6: 797-800.
23. Hatch FT, Lee RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968: 6: 2-68.
24. Yamada T, Uchiyama K, Yakata M, Gejyo F. Sandwich enzyme immunosassay for serum amyloid A protein (SAA). Clin Chim Acta 1989: 179: 169-176.
25. Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem 1974: 249: 5153-62.
26. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994: 37: 481-494.
27. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986: 112: 432-437.
28. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells. Implications for serum amyloid A function. Proc Natl Acad Sei USA 1994: 91: 3186-90.